Amgen (NASDAQ:AMGN) announced today that Repatha® (evolocumab), when added to statins or other low-density lipoprotein cholesterol (LDL-C)-lowering treatments, reduced the risk of first major adverse ...

Evolocumab (Repatha) reduced risk of a first major cardiovascular (CV) event in patients with diabetes but no known atherosclerosis in a substudy of the VESALIUS-CV trial. The PCSK9 inhibitor cut ...

A treadmill stress test highlights obstruction in the arteries; however, it does not draw attention to the vulnerable areas, according to Dr Kumar.

Artificial intelligence (AI)-based ECG interpretation outperformed standard pathways for the detection of occlusive ...

Receiving anti VEGF eye injections around the time of a stroke or heart attack is not linked to an increased risk for death ...

At 8 a.m., in an apartment in Guro-gu, Seoul. Kim, 69, was trying to button his dress shirt to go out when his right hand ...

Loss of the Y chromosome in circulating blood cells rises with age and is associated with increased heart attack risk, even ...

Ambient temperature is a key environmental driver of cardiovascular health. With rising global temperatures and increasing frequency, intensity, and duration of extreme temperature events, ...

A groundbreaking study reveals that an AI-based ECG interpretation method outperforms traditional diagnostic techniques in ...

A lot of the population through health education on radio and television stations, some health contents on social media, ...

Significantly lower risks for MACE, all-cause mortality, incident myocardial infarction, stroke seen for adults 50 years and older with ASCVD.